Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: BIOLOGICAL: dHER2 + AS15 ASCI|DRUG: Lapatinib
Sponsor: Michael Morse, MD
Collaborators: GlaxoSmithKline